Liabilities in USD of NKGen Biotech, Inc. from Q2 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
NKGen Biotech, Inc. quarterly Liabilities history and change rate from Q2 2021 to Q4 2024.
  • NKGen Biotech, Inc. Liabilities for the quarter ending 31 Dec 2024 was $86.1M, a 14.6% increase year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $86.1M +$11M +14.6% 31 Dec 2024 10-K 08 Oct 2025
Q3 2024 $62M -$3.79M -5.76% 30 Sep 2024 10-Q 04 Mar 2025
Q2 2024 $85.4M +$76M +813% 30 Jun 2024 10-Q 12 Sep 2024
Q1 2024 $71.4M +$65.1M +1034% 31 Mar 2024 10-Q 20 May 2024
Q4 2023 $75.2M +$60.4M +409% 31 Dec 2023 10-K 08 Oct 2025
Q3 2023 $65.8M +$60.3M +1079% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $9.35M +$3.11M +50% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $6.29M -$4.79M -43.2% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $14.8M +$1.3M +9.62% 31 Dec 2022 10-K 16 Apr 2024
Q3 2022 $5.58M -$6.84M -55.1% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $6.23M -$11.1M -64.1% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $11.1M 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $13.5M 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $12.4M 30 Sep 2021 10-Q/A 31 Jan 2022
Q2 2021 $17.4M 30 Jun 2021 10-Q/A 31 Jan 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.